C4 Therapeutics (CCCC) Operating Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24,154.00 |
| Dec 31, 2025 | 9,633.00 |
| Sep 30, 2025 | 13,456.00 |
| Jun 30, 2025 | -3,806.00 |
| Mar 31, 2025 | 32,547.00 |
| Dec 31, 2024 | -54,454.00 |
| Sep 30, 2024 | -526.00 |
| Jun 30, 2024 | 88,159.00 |
| Mar 31, 2024 | 8,753.00 |
| Dec 31, 2023 | -89,656.00 |
| Sep 30, 2023 | 115,905.00 |
| Jun 30, 2023 | -44,644.00 |
| Mar 31, 2023 | 37,796.00 |
| Dec 31, 2022 | -86,071.00 |
| Sep 30, 2022 | -28,307.00 |
| Jun 30, 2022 | 21,189.00 |
| Mar 31, 2022 | -33,386.00 |
| Dec 31, 2021 | 20,936.00 |
| Sep 30, 2021 | -5,923.00 |
| Jun 30, 2021 | 5,007.00 |
| Mar 31, 2021 | -4,738.00 |
| Dec 31, 2020 | -1,157.00 |
| Sep 30, 2020 | -10,493.00 |
| Jun 30, 2020 | 6,872.00 |
| Mar 31, 2020 | -5,312.00 |
| Dec 31, 2019 | 5,855.00 |